Deutsche Bank
RGNX icon

Deutsche Bank’s Regenxbio RGNX Stock Holding History

Deutsche Bank’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Buy
196,971
+4,389
+2% +$46.1K ﹤0.01% 1876
2025
Q4 		$2.77M Buy
192,582
+1,527
+0.8% +$19K ﹤0.01% 1613
2025
Q3 		$1.84M Buy
191,055
+3,790
+2% +$33.5K ﹤0.01% 1823
2025
Q2 		$1.54M Sell
187,265
-7,937
-4% -$66.4K ﹤0.01% 1857
2025
Q1 		$1.4M Sell
195,202
-5,173
-3% -$38.5K ﹤0.01% 1978
2024
Q4 		$1.55M Buy
200,375
+15,722
+9% +$148K ﹤0.01% 2002
2024
Q3 		$1.94M Buy
184,653
+26,679
+17% +$325K ﹤0.01% 1761
2024
Q2 		$1.85M Sell
157,974
-205
-0.1% -$3.19K ﹤0.01% 1683
2024
Q1 		$3.33M Buy
158,179
+140,025
+771% +$2.49M ﹤0.01% 1436
2023
Q4 		$326K Buy
18,154
+389
+2% +$6.85K ﹤0.01% 2608
2023
Q3 		$292K Buy
17,765
+2,827
+19% +$51.2K ﹤0.01% 2530
2023
Q2 		$299K Sell
14,938
-13,484
-47% -$260K ﹤0.01% 2660
2023
Q1 		$537K Sell
28,422
-1,060
-4% -$23.5K ﹤0.01% 2455
2022
Q4 		$669K Buy
29,482
+4,554
+18% +$103K ﹤0.01% 2290
2022
Q3 		$658K Sell
24,928
-2,363
-9% -$70.1K ﹤0.01% 2225
2022
Q2 		$675K Sell
27,291
-4,987
-15% -$125K ﹤0.01% 2414
2022
Q1 		$1.07M Buy
32,278
+447
+1% +$12.4K ﹤0.01% 2300
2021
Q4 		$1.04M Sell
31,831
-34,565
-52% -$1.18M ﹤0.01% 2415
2021
Q3 		$2.78M Sell
66,396
-678
-1% -$24.4K ﹤0.01% 1863
2021
Q2 		$2.6M Sell
67,074
-4,481
-6% -$160K ﹤0.01% 1987
2021
Q1 		$2.44M Buy
71,555
+7,628
+12% +$325K ﹤0.01% 2031
2020
Q4 		$2.9M Buy
63,927
+7,527
+13% +$263K ﹤0.01% 1672
2020
Q3 		$1.55M Sell
56,400
-39,855
-41% -$1.3M ﹤0.01% 1907
2020
Q2 		$3.54M Buy
96,255
+16,085
+20% +$600K ﹤0.01% 1486
2020
Q1 		$2.6M Sell
80,170
-15,159
-16% -$632K ﹤0.01% 1564
2019
Q4 		$3.9M Buy
95,329
+48,387
+103% +$1.91M ﹤0.01% 1597
2019
Q3 		$1.67M Sell
46,942
-1,427
-3% -$57.8K ﹤0.01% 2020
2019
Q2 		$2.48M Sell
48,369
-254,157
-84% -$12.7M ﹤0.01% 2254
2019
Q1 		$17.3M Sell
302,526
-126,845
-30% -$6.28M 0.01% 1062
2018
Q4 		$18M Buy
429,371
+73,397
+21% +$4.31M 0.01% 943
2018
Q3 		$26.9M Buy
355,974
+111,843
+46% +$8.06M 0.01% 966
2018
Q2 		$17.5M Sell
244,131
-99,622
-29% -$4.76M 0.01% 1277
2018
Q1 		$10.3M Buy
343,753
+162,113
+89% +$4.72M ﹤0.01% 1598
2017
Q4 		$6.04M Sell
181,640
-12,335
-6% -$372K ﹤0.01% 1873
2017
Q3 		$6.39M Buy
193,975
+13,266
+7% +$299K ﹤0.01% 1759
2017
Q2 		$3.57M Buy
180,709
+70,403
+64% +$1.36M ﹤0.01% 2160
2017
Q1 		$2.13M Buy
110,306
+47,278
+75% +$912K ﹤0.01% 2205
2016
Q4 		$1.17M Buy
63,028
+24,061
+62% +$460K ﹤0.01% 2597
2016
Q3 		$544K Buy
38,967
+8,070
+26% +$89.1K ﹤0.01% 3150
2016
Q2 		$246K Buy
30,897
+2,017
+7% +$22.4K ﹤0.01% 3661
2016
Q1 		$311K Sell
28,880
-720
-2% -$9.21K ﹤0.01% 3456
2015
Q4 		$490K Buy
29,600
+1,822
+7% +$36.2K ﹤0.01% 3283
2015
Q3 		$611K Buy
+27,778
New +$709K ﹤0.01% 3257

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's RGNX Position: Q1 2026 in Review

Deutsche Bank increased its Regenxbio (RGNX) stake by 2.3% in Q1 2026, buying an estimated $46.1K and bringing the position to 196,971 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

Deutsche Bank first reported a position in RGNX in Q3 2015 and has held it in 43 quarters since. The position peaked at $26.9M in Q3 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Deutsche Bank held 196,971 shares of Regenxbio worth $1.65M as of Q1 2026.
  • Deutsche Bank bought 4,389 Regenxbio shares in Q1 2026, an estimated $46.1K.
  • Regenxbio made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1876 holding.
  • Deutsche Bank first reported a position in Regenxbio in Q3 2015 and has held it in 43 quarters since.
  • Deutsche Bank's Regenxbio position peaked at $26.9M in Q3 2018.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.